
Alight, Inc. (NYSE:ALIT), a leading benefits administration provider of health, wealth and leave solutions, today announced the addition of eMed Population Health, Inc., a platform for employer-sponsored preventative

<p xmlns="http://www.w3.org/1999/xhtml">
<a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.alight.com&amp;esheet=54586830&amp;newsitemid=20260811005256&amp;lan=en-US&amp;anchor=Alight%2C+Inc.&amp;index=1&amp;md5=18bdd09f40dcf7ab437a497e20611e8c" shape="rect">Alight, Inc.</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/ALIT">ALIT</a>), a leading benefits administration provider of health, wealth and leave solutions, today announced the addition of <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.emed.com%2F&amp;esheet=54586830&amp;newsitemid=20260811005256&amp;lan=en-US&amp;anchor=eMed+Population+Health%2C+Inc.&amp;index=2&amp;md5=699a3ff7d6f6dd1dc44737976dabdc45" shape="rect">eMed Population Health, Inc.</a>, a platform for employer-sponsored preventative health management, to the Alight Partner Network. The collaboration will enhance employer-sponsored access to GLP-1 therapies and give organizations a scalable way to support eligible employees, improve adherence to treatment and address the cost and complexity of weight management benefits.

</p><p xmlns="http://www.w3.org/1999/xhtml">
The groundswell of interest in GLP-1 medications among the general population has soared in recent years — 11% of U.S. adults now take GLP-1 medications for weight loss, up from 3% in 2024, according to <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fnews.gallup.com%2Fpoll%2F712157%2Fglp-usage-reaches-new-high.aspx&amp;esheet=54586830&amp;newsitemid=20260811005256&amp;lan=en-US&amp;anchor=Gallup%27s+National+Health+and+Well-Being+Index&amp;index=3&amp;md5=748522080f39990be7f3a77bc05b4c6d" shape="rect">Gallup&#39;s National Health and Well-Being Index</a>. As demand for obesity and chronic condition management continues to rise, employers are seeking solutions that foster long-term workforce health while helping manage healthcare costs.

</p><p xmlns="http://www.w3.org/1999/xhtml">
By adding eMed to its Partner Network, Alight is expanding its health ecosystem with an industry-leading, flexible, outcomes-focused GLP-1 solution designed to support employers across a range of workforce health goals, benefits strategies and coverage approaches. Through a connected experience that includes clinical evaluation, treatment access, adherence support and ongoing engagement, organizations can provide eligible employees with personalized care, regardless of their coverage needs, while gaining greater visibility into utilization and outcomes.

</p><p xmlns="http://www.w3.org/1999/xhtml">
"Employers are looking for smarter, more sustainable ways to address rising healthcare costs while improving outcomes for their people," said Jessica Borchik, SVP, Partner Strategy and Sales at Alight. "By welcoming eMed into our Partner Network, we’re expanding access to a clinically rigorous, outcomes-focused approach to GLP-1 management that helps organizations support employee health while maintaining cost control."

</p><p xmlns="http://www.w3.org/1999/xhtml">
The collaboration reflects a shared commitment to helping employers, including Fortune 500 companies already supported by Alight, implement GLP-1 programs that align with their unique needs while improving health outcomes and managing costs.

</p><p xmlns="http://www.w3.org/1999/xhtml">
"We’re at a pivotal moment in healthcare where employers have an opportunity to fundamentally change the trajectory of population health and chronic diseases," said Greg Page, SVP Partnerships &amp; Strategy at eMed. "By partnering with Alight, we’re combining access and accountability in a way that helps organizations improve employee health, manage costs, and realize the full promise of GLP-1 therapies."

</p><p xmlns="http://www.w3.org/1999/xhtml">
Together, Alight and eMed will provide employers with a scalable way to manage utilization, improve adherence and reduce avoidable healthcare spend while delivering a more connected and personalized health experience for eligible employees.

</p><p xmlns="http://www.w3.org/1999/xhtml">
To learn more about Alight’s Partner Network, visit <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.alight.com%2Fpartners%2Fpartner-network&amp;esheet=54586830&amp;newsitemid=20260811005256&amp;lan=en-US&amp;anchor=alight.com&amp;index=4&amp;md5=d96eb142229327c6425b8647a1b7e2ae" shape="rect">alight.com</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">About Alight Solutions</b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
Alight is a leading benefits administration provider of health, wealth, leave and point solutions for many of the world’s largest organizations and over 30 million people. Through the administration of employee benefits, Alight helps clients gain a benefits advantage while building a health and financially secure workforce by unifying the benefits ecosystem across health, wealth, wellbeing, absence management and navigation. Our Alight Worklife&#xAE; platform empowers employers to gain a deeper understanding of their workforce and engage them throughout life’s most important moments with personalized benefits management and data-driven insights, leading to increased employee wellbeing, engagement and productivity. Learn more at <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Falight.com%2F&amp;esheet=54586830&amp;newsitemid=20260811005256&amp;lan=en-US&amp;anchor=alight.com&amp;index=5&amp;md5=182a6ffeec93709b4c2c4f40467cba01" shape="rect">alight.com</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">About eMed</b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
eMed is the world’s first end-to-end GLP-1 care platform built on Empathetic AI&#x2122;. From remote diagnostics and clinician-led prescriptions to adherence coaching and insights, eMed empowers employers to manage population health with accountability and compassion. Learn more at <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.emed.com%2F&amp;esheet=54586830&amp;newsitemid=20260811005256&amp;lan=en-US&amp;anchor=www.eMed.com&amp;index=6&amp;md5=14a12b3f985e06375700d3e507d8f3ba" shape="rect">www.eMed.com</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml"><img xmlns="http://www.w3.org/1999/xhtml" alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260811005256r1&amp;sid=benz2&amp;distro=nx&amp;lang=en" style="width:0;height:0"></img><span xmlns="http://www.w3.org/1999/xhtml" class="bwct31415"></span></p><p xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink"><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-phrase">View source version on businesswire.com: </span><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-link"><a xmlns="http://www.w3.org/1999/xhtml" href="https://www.businesswire.com/news/home/20260811005256/en/" rel="nofollow">https://www.businesswire.com/news/home/20260811005256/en/</a></span></p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">Media Contacts 
</b><br xmlns="http://www.w3.org/1999/xhtml"></br>Jenna Jordan (for Alight)
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:Mediarelations@alight.com" shape="rect">Mediarelations@alight.com</a>

</p>

ALIT

Alight and eMed Join Forces to Expand Access to GLP-1 Therapies for Employers, Advancing Population and Workforce Health

Alight expands GLP-1 reach via eMed partnership in Partner Network

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>Alight, Inc. (NYSE:ALIT), a leading benefits administration provider of health, wealth and leave solutions, today announced the addition of eMed Population Health, Inc., a platform for employer-sponsored preventative</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Alight announced the addition of eMed Population Health to its Partner Network to broaden access to GLP-1 therapies for employer-sponsored programs. The move comes as GLP-1 adoption accelerates, with 11% of U.S. adults using GLP-1 meds for weight loss, up from 3% in 2024, according to Gallup. The collaboration aims to improve treatment adherence, reduce avoidable costs, and leverage Alight’s Fortune 500 client base to drive incremental revenue.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Alight adds eMed Population Health to Partner Network to expand GLP-1 access.</li><li>11% of U.S. adults use GLP-1 meds for weight loss, up from 3% in 2024.</li><li>Collaboration aims to improve access, adherence, and cost control for employers.</li><li>Fortune 500 clients already rely on Alight&#039;s benefits platform.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Alight, Inc. (ALIT)</strong>: Announces integration of eMed into Partner Network to expand GLP-1 solutions.</li><li><strong>eMed Population Health, Inc. (EMED)</strong>: Partner expanding GLP-1 access within ALIT’s network; potential revenue impact.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>Category: Corporate Developments. The move reflects a strategic healthcare benefits expansion to broaden GLP-1 program reach via a partner ecosystem, signaling potential long-term growth in ALIT’s services and cost-management offerings.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>GLP-1 adoption tailwinds could lift ALIT&#039;s partner-service utilization.</li><li>eMed collaboration may expand revenue streams with Fortune 500 clients.</li><li>No immediate earnings impact; potential upside materializes over quarters.</li><li>Regulatory/payer dynamics in GLP-1 could influence costs and pricing.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Date: August 11, 2026.</li><li>11% of U.S. adults use GLP-1 meds for weight loss; up from 3% in 2024 (Gallup index).</li><li>Alight notes Fortune 500 clients already supported by its platform.</li><li>eMed Population Health, Inc. joining Alight&#039;s Partner Network to expand GLP-1 access.</li><li>eMed is described as an end-to-end GLP-1 care platform built on Empathetic AI.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Over the next 6–12 months, ALIT could see measurable upside from this GLP-1 partnership.</p>
  </section>
</section>


<p xmlns="http://www.w3.org/1999/xhtml">
<a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.alight.com&amp;esheet=54586830&amp;newsitemid=20260811005256&amp;lan=en-US&amp;anchor=Alight%2C+Inc.&amp;index=1&amp;md5=18bdd09f40dcf7ab437a497e20611e8c" shape="rect">Alight, Inc.</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/ALIT">ALIT</a>), a leading benefits administration provider of health, wealth and leave solutions, today announced the addition of <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.emed.com%2F&amp;esheet=54586830&amp;newsitemid=20260811005256&amp;lan=en-US&amp;anchor=eMed+Population+Health%2C+Inc.&amp;index=2&amp;md5=699a3ff7d6f6dd1dc44737976dabdc45" shape="rect">eMed Population Health, Inc.</a>, a platform for employer-sponsored preventative health management, to the Alight Partner Network. The collaboration will enhance employer-sponsored access to GLP-1 therapies and give organizations a scalable way to support eligible employees, improve adherence to treatment and address the cost and complexity of weight management benefits.

</p><p xmlns="http://www.w3.org/1999/xhtml">
The groundswell of interest in GLP-1 medications among the general population has soared in recent years — 11% of U.S. adults now take GLP-1 medications for weight loss, up from 3% in 2024, according to <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fnews.gallup.com%2Fpoll%2F712157%2Fglp-usage-reaches-new-high.aspx&amp;esheet=54586830&amp;newsitemid=20260811005256&amp;lan=en-US&amp;anchor=Gallup%27s+National+Health+and+Well-Being+Index&amp;index=3&amp;md5=748522080f39990be7f3a77bc05b4c6d" shape="rect">Gallup&#39;s National Health and Well-Being Index</a>. As demand for obesity and chronic condition management continues to rise, employers are seeking solutions that foster long-term workforce health while helping manage healthcare costs.

</p><p xmlns="http://www.w3.org/1999/xhtml">
By adding eMed to its Partner Network, Alight is expanding its health ecosystem with an industry-leading, flexible, outcomes-focused GLP-1 solution designed to support employers across a range of workforce health goals, benefits strategies and coverage approaches. Through a connected experience that includes clinical evaluation, treatment access, adherence support and ongoing engagement, organizations can provide eligible employees with personalized care, regardless of their coverage needs, while gaining greater visibility into utilization and outcomes.

</p><p xmlns="http://www.w3.org/1999/xhtml">
"Employers are looking for smarter, more sustainable ways to address rising healthcare costs while improving outcomes for their people," said Jessica Borchik, SVP, Partner Strategy and Sales at Alight. "By welcoming eMed into our Partner Network, we’re expanding access to a clinically rigorous, outcomes-focused approach to GLP-1 management that helps organizations support employee health while maintaining cost control."

</p><p xmlns="http://www.w3.org/1999/xhtml">
The collaboration reflects a shared commitment to helping employers, including Fortune 500 companies already supported by Alight, implement GLP-1 programs that align with their unique needs while improving health outcomes and managing costs.

</p><p xmlns="http://www.w3.org/1999/xhtml">
"We’re at a pivotal moment in healthcare where employers have an opportunity to fundamentally change the trajectory of population health and chronic diseases," said Greg Page, SVP Partnerships &amp; Strategy at eMed. "By partnering with Alight, we’re combining access and accountability in a way that helps organizations improve employee health, manage costs, and realize the full promise of GLP-1 therapies."

</p><p xmlns="http://www.w3.org/1999/xhtml">
Together, Alight and eMed will provide employers with a scalable way to manage utilization, improve adherence and reduce avoidable healthcare spend while delivering a more connected and personalized health experience for eligible employees.

</p><p xmlns="http://www.w3.org/1999/xhtml">
To learn more about Alight’s Partner Network, visit <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.alight.com%2Fpartners%2Fpartner-network&amp;esheet=54586830&amp;newsitemid=20260811005256&amp;lan=en-US&amp;anchor=alight.com&amp;index=4&amp;md5=d96eb142229327c6425b8647a1b7e2ae" shape="rect">alight.com</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">About Alight Solutions</b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
Alight is a leading benefits administration provider of health, wealth, leave and point solutions for many of the world’s largest organizations and over 30 million people. Through the administration of employee benefits, Alight helps clients gain a benefits advantage while building a health and financially secure workforce by unifying the benefits ecosystem across health, wealth, wellbeing, absence management and navigation. Our Alight Worklife&#xAE; platform empowers employers to gain a deeper understanding of their workforce and engage them throughout life’s most important moments with personalized benefits management and data-driven insights, leading to increased employee wellbeing, engagement and productivity. Learn more at <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Falight.com%2F&amp;esheet=54586830&amp;newsitemid=20260811005256&amp;lan=en-US&amp;anchor=alight.com&amp;index=5&amp;md5=182a6ffeec93709b4c2c4f40467cba01" shape="rect">alight.com</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">About eMed</b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
eMed is the world’s first end-to-end GLP-1 care platform built on Empathetic AI&#x2122;. From remote diagnostics and clinician-led prescriptions to adherence coaching and insights, eMed empowers employers to manage population health with accountability and compassion. Learn more at <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.emed.com%2F&amp;esheet=54586830&amp;newsitemid=20260811005256&amp;lan=en-US&amp;anchor=www.eMed.com&amp;index=6&amp;md5=14a12b3f985e06375700d3e507d8f3ba" shape="rect">www.eMed.com</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml"><img xmlns="http://www.w3.org/1999/xhtml" alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260811005256r1&amp;sid=benz2&amp;distro=nx&amp;lang=en" style="width:0;height:0"></img><span xmlns="http://www.w3.org/1999/xhtml" class="bwct31415"></span></p><p xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink"><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-phrase">View source version on businesswire.com: </span><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-link"><a xmlns="http://www.w3.org/1999/xhtml" href="https://www.businesswire.com/news/home/20260811005256/en/" rel="nofollow">https://www.businesswire.com/news/home/20260811005256/en/</a></span></p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">Media Contacts 
</b><br xmlns="http://www.w3.org/1999/xhtml"></br>Jenna Jordan (for Alight)
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:Mediarelations@alight.com" shape="rect">Mediarelations@alight.com</a>

</p>

Alight announced the addition of eMed Population Health to its Partner Network to broaden access to GLP-1 therapies for employer-sponsored programs. The move comes as GLP-1 adoption accelerates, with 11% of U.S. adults using GLP-1 meds for weight loss, up from 3% in 2024, according to Gallup. The collaboration aims to improve treatment adherence, reduce avoidable costs, and leverage Alight’s Fortune 500 client base to drive incremental revenue.

News insight

Alight and eMed Join Forces to Expand Access to GLP-1 Therapies for Employers, Advancing Population and Workforce Health

AI summary

Sentiment rationale

Key facts

Corporate Developments